• Ming Jin, Ningning Wang, Xueyan Li, Hao Zhang, Jexin Zhou, Mingyu Cong, Jun Niu, Chongyang Lin, Ying Hu, Nan Wu, Jicheng Liu, Keyong Zhang, and Changchun Qiu.
• Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang Province, People's Republic of China.
• Medicine (Baltimore). 2022 Sep 23; 101 (38): e30562.

AbstractIschemic stroke, one of the prevalent causes of death and disability worldwide, is linked to environmental and genetic factors, including polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene involved in homocysteine metabolism. The present study aimed to explore the relationship between the MTHFR C677T variant, plasma homocysteine, and risk of developing large-artery atherosclerotic ischemic stroke (LAAIS) among Han Chinese. A population-based case-control study, which included 1810 patients with LAAIS and 1765 unrelated control subjects, was conducted. Compared to the controls, LAAIS patients had a significantly higher prevalence of hypertension, diabetes mellitus, smoking, and alcohol consumption (P < .001), as well as significantly higher mean fasting blood glucose, triglyceride, total cholesterol, and plasma homocysteine levels (P < .001). The TT homozygous genotype correlated with increased risk of developing LAAIS, as indicated by a significantly higher odds ratio (OR) compared to the CT and CC genotypes, in both additive (OR = 3.215, P = .01) and recessive models (OR = 3.265, P = .01). The plasma homocysteine level was genotype-dependent according to the following trend: TT > CT > CC. In conclusion, our data demonstrate that, in spite of its low prevalence in both patients and controls (1.5% vs 0.8%), the MTHFR C677T variant could, at least in part, affect homocysteine levels and this, either alone or in combination with other factors, increases the risk of LAAIS.Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

31 keywords...

hide…